(2VOL).KELLEY Y FIRESTEIN:TRATADO REUMATOLOGIA+EXPERT

• Cubre todos los aspectos, desde la ciencia básica, la inmunología, la anatomía y la fisiología, hasta las pruebas diagnósticas, los procedimientos, la exploración física y la patogenia, las manifestaciones y el tratamiento de la enfermedad, e incluye datos clave sobre resultados terapéuticos para tomar decisiones clínicas bien documentadas.
• Incorpora capítulos nuevos o significativamente revisados: "Autoinmunidad preclínica"; "El microbioma en las enfermedades reumáticas"; "Terapia ocupacional, fisioterapia y rehabilitación"; "Nutrición y enfermedades reumáticas"; "Clasificación y epidemiología de las espondiloartritis"; "Etiología y patogenia de la artrosis"; "COVID-19 y enfermedad reumática"; "Vacunación en las enfermedades reumáticas", y "Complicaciones autoinmunitarias de los inhibidores de los puntos de control inmunitario para el cáncer", entre otros.
• Incluye 1.200 ilustraciones de alta calidad, con magníficos esquemas, tablas de referencia rápida y fotografías clínicas en color; muchas de las nuevas ilustraciones ponen de relieve las enfermedades en poblaciones de distintos orígenes. Comparte los conocimientos y la experiencia de científicos y clínicos de renombre internacional, entre los que se cuentan los nuevos editores, los doctores Ted Mikuls y Tuhina Neogi.
• Incluye acceso a la versión electrónica del libro (en inglés). Este ebook permite consultar el texto, las imágenes y las referencias bibliográficas, con la posibilidad de realizar búsquedas, personalizar el contenido, tomar notas y resaltar el texto, así como reproducir el contenido en audio
• Se incluyen, además, vídeos que muestran la exploración musculoesquelética, los hallazgos anormales y la presentación artroscópica de la patología articular.

Con su enfoque exhaustivo e integral de todos los aspectos del diagnóstico, el cribado y el tratamiento, tanto en pacientes adultos como pediátricos, Firestein y Kelley. Tratado de reumatología sigue siendo la referencia de elección en esta especialidad. La duodécima edición, completamente revisada, mantiene el formato a todo color, y proporciona una orientación sistemática en reumatología para lograr un equilibrio ideal entre ciencia básica y aplicación clínica. Nuevos editores, nuevos capítulos y nuevas ilustraciones le mantendrán al día acerca de los recientes avances en genética y microbioma, las terapias actuales y otras innovaciones en este campo.

Gary Firestein, MD, is a board-certified rheumatologist who diagnoses and treats patients with autoimmune conditions as well as diseases of the joints, muscles and bones. A professor at UC San Diego School of Medicine, Dr. Firestein is distinguished for his research and serves as director of the Altman Clinical and Translational Research Institute and the senior associate vice chancellor for health sciences. Dr. Firestein's research interest focuses on the pathogenesis and treatment of rheumatoid arthritis.
Dr. Firestein is the recipient of many awards and honors, including the Arthritis Foundation's Jane Wyman Humanitarian Award in 2010 for his contributions to rheumatology; the Arthritis Foundation Lee C. Howley Sr. Prize for Arthritis Research; and the American College of Rheumatology Distinguished Investigator Award. He has been elected to the American Society for Clinical Investigation and the Association of American Physicians. He has served as an editor for the Textbook of Rheumatology for since the 7th edition (2004).

Iain McInnes is Director of the Institute of Infection, Immunity and Inflammation at the University of Glasgow, UK. He has extensive experience in leading multicenter programs nationally and internationally. He is Director of the Scottish MRC Clinical Pharmacology and Pathology Clinical PhD Training Program, Chief Investigator for the Scottish Early RA Cohort (SERA) and the related SMS-IC biomarker discovery program (PROMISERA), and chief investigator of numerous global phase II and III clinical trials of novel immune therapies. He has served as member or chair of numerous national grant-funding panels and as chair of several European League Against Rheumatism (EULAR) scientific committees – he is now Treasurer and President Elect of EULAR serving on its Steering Committee. He is formerly Chairman of the Foundation for European Rheumatology Research (Foreum) Scientific Committee and leads the EULAR-supported European Roadmap Program that is defining the research agenda for rheumatology for the next decade.

Gary Koretzky, MD, PhD is Professor of Medicine at Weill Cornell Graduate School. Dr. Koretzky’s research aims to better understand the signal transduction events that occur following engagement of the T cell antigen receptor. He has been continuously funded by the National Institutes of Health since establishing his independent research group, as the laboratory has expanded its interests to study more globally the molecular events important for immune cell development, differentiation and function. Dr. Koretzky has published more than 200 research articles. He is a past President of the American Society of Clinical Investigation (2000) and Councilor of the Association of American Physicians (2008-2012), is a Fellow of the American Association for the Advancement of Science (2004), a member of the Institute of Medicine of the National Academies (2008), a Fellow of the American Academy of Arts & Sciences (2012) and serves as the Editor-in-Chief of Immunological Reviews (2002-present).

Dr. Mikuls is a rheumatologist and epidemiologist with research interests focused on the epidemiology, pathogenesis, and outcomes of rheumatoid arthritis (RA) and gout. He is actively engaged in clinical/translational research activities and has received research funding from the NIH, U.S. Department of Defense, Veterans Affairs, the Rheumatology Research Foundation, and industry. He has extensive experience conducting multi-center / multidisciplinary trials, serving as the Principal Investigator (PI) for the multicenter Veterans Affairs Rheumatoid Arthritis (VARA) registry since its inception in 2003. He has served on multiple national study sections including those convened by the NIH, VA, and the Rheumatology Research Foundation. He previously chaired the American College of Rheumatology (ACR) Subcommittee for Practice Guidelines, served on the US FDA’s Arthritis Advisory Committee, and was the Lead Editor for the textbook A Color Handbook – Rheumatology.

Tuhina Neogi is a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. Dr. Neogi has had continuous peer-reviewed foundation and NIH funding since 2003 and has over 250 peer-reviewed publications to date. She is a past chair of the FDA Arthritis Advisory Committee, serve(d) on the boards of two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. Her work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research and she has also engaged in developing new classification criteria for a number of rheumatic diseases.